HeartCore sells 51% Sigmaways stake to Semaphore
HeartCore Enterprises agreed to sell its 51% interest in Sigmaways to Semaphore Technologies for up to $650,000. This divestiture reduces the company's controlling ownership in the subsidiary.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
GET FREE KEY — 10,000 calls/day